Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Verastem (VSTM) Other Non Operating Income: 2018-2025

Historic Other Non Operating Income for Verastem (VSTM) over the last 4 years, with Sep 2025 value amounting to -$37,000.

  • Verastem's Other Non Operating Income rose 51.95% to -$37,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 1264.58%. This contributed to the annual value of -$123,000 for FY2024, which is 12.84% down from last year.
  • As of Q3 2025, Verastem's Other Non Operating Income stood at -$37,000, which was up 66.36% from -$110,000 recorded in Q2 2025.
  • In the past 5 years, Verastem's Other Non Operating Income ranged from a high of $28,000 in Q1 2022 and a low of -$1.8 million during Q1 2025.
  • Over the past 3 years, Verastem's median Other Non Operating Income value was -$33,500 (recorded in 2024), while the average stood at -$215,600.
  • Data for Verastem's Other Non Operating Income shows a peak YoY increase of 51.95% (in 2025) and a maximum YoY decrease of 5,986.67% (in 2025) over the last 5 years.
  • Verastem's Other Non Operating Income (Quarterly) stood at -$7,000 in 2022, then tumbled by 165.00% to -$13,000 in 2023, then plummeted by 492.31% to $8,000 in 2024, then skyrocketed by 51.95% to -$37,000 in 2025.
  • Its last three reported values are -$37,000 in Q3 2025, -$110,000 for Q2 2025, and -$1.8 million during Q1 2025.